AI | MyInVitroAnswer.com

top of page

A silhouette of young man is facing his computer twin. The individual on the left is a biological entity with a visible brain, holding his patient-derived brain organoid. The individual on the right is a circuit board figure in blue, holding a blue sphere. The image symbolizes complementary between a real-world patient and his digital twin.

A silhouette of young man is facing his computer twin. The individual on the left is a biological entity with a visible brain, holding his patient-derived brain organoid. The individual on the right is a circuit board figure in blue, holding a blue sphere. The image symbolizes complementary between a real-world patient and his digital twin.

Digital Human Twins: Transforming the Future of Human Health

Hybrid AI-in vitro platforms

Hesperos establishes strategic sales partnership with AsedaSciences to augment compound safety prediction

Hesperos establishes strategic sales partnership with AsedaSciences to augment compound safety prediction

Hesperos establishes strategic sales partnership with AsedaSciences to augment compound safety prediction

Intra-industry partnerships

Illustration showing two paths that lead to an antibody, depicting converging pathways toward development of in vitro antibody generation platform.

Illustration showing two paths that lead to an antibody, depicting converging pathways toward development of in vitro antibody generation platform.

Prellis Biologics joins forces with Eli Lilly to transform how target-specific human antibodies are generated

Pharma & biotech collaborations

Cedars-Sinai KronosRx team awarded $5M to improve prediction of adverse drug effects

Grants Awarded & Funds Raised

Parallel Bio raises $21M to expand its human immune organoid platform

Grants Awarded & Funds Raised

Qureator's preclinical tumor model featured in world's first animal-free IND approval

Qureator's preclinical tumor model featured in world's first animal-free IND approval

Qureator's preclinical tumor model featured in world's first animal-free IND approval

Clinical Trial Authorizations

Inductive Bio awarded $21M by ARPA-H to improve drug toxicity prediction

Grants Awarded & Funds Raised

bottom of page